Ewing sarcoma

Ewing sarcoma is an aggressive cancer of bone or soft tissue, usually defined by a characteristic gene fusion. Treatment addresses both the visible tumor and the risk of disease elsewhere in the body.

Other names and abbreviations

Ewing's sarcoma, EWS, Ewing family tumor, Ewing tumor, peripheral primitive neuroectodermal tumour (historical when EWSR1-ETS fusion-defined)

In short

  • Ewing sarcoma is an aggressive cancer of bone or soft tissue that mainly affects children, teens and young adults.
  • Treatment combines several chemotherapy drugs with surgery, radiation or both, to treat the main tumor and lower the risk of disease elsewhere in the body.
  • Some high-risk patients may get high-dose chemotherapy followed by a return of their own stem cells, which is not routine and normally does not use a registry donor.
Jump to a section

Underlined words open a short explanation. See all terms

Where transplant fits

Selected high-risk patients may receive with . The value of this approach depends on the specific setting; it is not routine for every Ewing sarcoma and normally uses the patient’s cells, not a registry donor.

Treatment depends on the exact diagnosis, disease stage, prior treatment and the person’s health.

Key facts

Who it affects
Ewing sarcoma mainly affects children, adolescents and young adults.
Usual treatment
Multi-drug chemotherapy is combined with surgery and/or radiation for local control. High-dose chemotherapy is used in selected high-risk settings, with choice guided by the protocol, disease extent and prior response.
Cells used in a transplant
The patient’s own collected blood-forming cells for autologous stem cell rescue, when that procedure is appropriate.
Where a donor fits
Limited transplant role

Support for patients and families

These independent organizations offer information and support. JBF is not affiliated with them.

Questions to bring to your care team

  • What is the exact name of the diagnosis or subtype, and what does it mean for treatment?
  • What is the goal of each treatment you are suggesting?
  • What would make a transplant worth considering later on?
  • Are there clinical trials that might fit?
  • Where can our family find support during treatment?

Supporting someone with a diagnosis

Sources and further reading

  1. Ewing Sarcoma Treatment (PDQ)
    NCI, Accessed 2026-09-05
  2. Indications for haematopoietic cell transplantation and CAR-T: 2025 EBMT practice recommendations
    EBMT / Bone Marrow Transplantation, Accessed 2026-09-05
  3. Stem Cell and Bone Marrow Transplants for Cancer
    NCI, Accessed 2026-09-05

Other patients are waiting for a match.

Most people with Ewing sarcoma are treated without a registry donor. Many people with other blood cancers and blood disorders need a donor who is a stranger.

Join the registry

JBF points you to the official registry that serves your country. It explains who can join and what donation involves.

Help a family run a drive

If someone you love needs a donor, a registration drive can add many potential donors at once, for them and for others.

Support this work

Gifts to the Jada Bascom Foundation support donor-awareness education like this guide, community outreach, drive planning and referrals to official registries.

Donate to JBF

We respect your privacy. Unsubscribe anytime.

Keep learning